A detailed history of Vericrest Private Wealth transactions in Precision Biosciences Inc stock. As of the latest transaction made, Vericrest Private Wealth holds 154,694 shares of DTIL stock, worth $1.25 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
154,694
Holding current value
$1.25 Million
% of portfolio
0.3%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$1.15 - $3.34 $177,898 - $516,677
154,694 New
154,694 $248,000

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $894M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Vericrest Private Wealth Portfolio

Follow Vericrest Private Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vericrest Private Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Vericrest Private Wealth with notifications on news.